TDC
BLFS icon

Thompson Davis & Co’s BioLife Solutions BLFS Stock Holding History

Thompson Davis & Co’s Portfolio BLFS Stock Details BLFS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-4,000
Closed -$24K – 633
2017
Q4 		$24K Buy
4,000
+3,750
+1,500% +$21.6K 0.06% 293
2017
Q3 		$1K Buy
+250
New +$1.04K ﹤0.01% 1058

Other funds holding BLFS

SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
EIM
Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return
GIP
Granite Investment Partners El Segundo, California $1.63B AUM 38.09% 1-Year Est. Return
EI
EAM Investors Solana Beach, California $866M AUM 377.14% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MHP
Manatuck Hill Partners Westport, Connecticut $370M AUM 95.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
KIA
Kopp Investment Advisors Bloomington, Minnesota $54.4M AUM 14.33% 1-Year Est. Return

Thompson Davis & Co's BLFS Position: Q1 2018 in Review

Thompson Davis & Co sold out of BioLife Solutions (BLFS) in Q1 2018, closing a stake of 4,000 shares — an estimated $24K sold.

Thompson Davis & Co first reported a position in BLFS in Q3 2017 and held it in 2 quarters. The position peaked at $24K in Q4 2017. 30 funds tracked by Wall St. Rank hold BLFS as of Q1 2018.

  • Thompson Davis & Co reported no remaining BioLife Solutions position as of Q1 2018 after selling out during the quarter.
  • Thompson Davis & Co sold 4,000 BioLife Solutions shares in Q1 2018, an estimated $24K.
  • Thompson Davis & Co first reported a position in BioLife Solutions in Q3 2017 and held it in 2 quarters.
  • Thompson Davis & Co's BioLife Solutions position peaked at $24K in Q4 2017.
  • 30 funds tracked by Wall St. Rank held BioLife Solutions as of Q1 2018.

Based on Thompson Davis & Co's 13F filing for Q1 2018, filed 2 May 2018.